These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 17485751)

  • 1. Educating patients about their medications: the potential and limitations of written drug information.
    Shrank WH; Avorn J
    Health Aff (Millwood); 2007; 26(3):731-40. PubMed ID: 17485751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Communicating with patients about their medications.
    Kessler DA
    N Engl J Med; 1991 Dec; 325(23):1650-2. PubMed ID: 1944456
    [No Abstract]   [Full Text] [Related]  

  • 3. Literacy demands of product information intended to supplement television direct-to-consumer prescription drug advertisements.
    Kaphingst KA; Rudd RE; DeJong W; Daltroy LH
    Patient Educ Couns; 2004 Nov; 55(2):293-300. PubMed ID: 15530767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To err is human: patient misinterpretations of prescription drug label instructions.
    Wolf MS; Davis TC; Shrank W; Rapp DN; Bass PF; Connor UM; Clayman M; Parker RM
    Patient Educ Couns; 2007 Aug; 67(3):293-300. PubMed ID: 17587533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical review of FDA-approved Medication Guides.
    Wolf MS; Davis TC; Shrank WH; Neuberger M; Parker RM
    Patient Educ Couns; 2006 Sep; 62(3):316-22. PubMed ID: 16884888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 7. Consumer understanding of prescription drug information: an illustration using an antidepressant medication.
    Shiffman S; Gerlach KK; Sembower MA; Rohay JM
    Ann Pharmacother; 2011 Apr; 45(4):452-8. PubMed ID: 21427296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do medication samples jeopardize patient safety?
    Franks AS; Ray SM; Wallace LS; Keenum AJ; Weiss BD
    Ann Pharmacother; 2009 Jan; 43(1):51-6. PubMed ID: 19092144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On narrowing the patient-doctor communications gap.
    FDA Consum; 1982 May; 16(4):19-21. PubMed ID: 10309635
    [No Abstract]   [Full Text] [Related]  

  • 10. Written medicine information from English-speaking countries--how does it compare?
    Luk A; Tasker N; Raynor DK; Aslani P
    Ann Pharmacother; 2010 Feb; 44(2):285-94. PubMed ID: 20103613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suitability and readability of consumer medical information accompanying prescription medication samples.
    Wallace LS; Keenum AJ; Roskos SE; Blake GH; Colwell ST; Weiss BD
    Patient Educ Couns; 2008 Mar; 70(3):420-5. PubMed ID: 18178363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
    Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA proposes patient package inserts for most drugs.
    Mayberger HW; Bell BJ
    Leg Aspects Med Pract; 1979 Oct; 7(10):42-4. PubMed ID: 263192
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1982 Sep; 47(173):39147-55. PubMed ID: 10258154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of reading additional safety information on planned use of over-the-counter analgesics.
    McDonald DD; Amendola MG; Interlandi E; Wall K; Lewchik B; Polouse L; Pace N; Inthavong S; Li L
    Public Health Nurs; 2007; 24(3):230-8. PubMed ID: 17456124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisapride and patient information leaflets.
    Sukkari SR; Sasich LD
    CMAJ; 2001 May; 164(9):1276-8; author reply 1278-9. PubMed ID: 11341134
    [No Abstract]   [Full Text] [Related]  

  • 19. An exploratory study of drug abuse and dependence information in package inserts.
    Phipps LB; Balster RL; Slattum PW; Kirkwood CK
    J Addict Dis; 2007; 26(2):25-34. PubMed ID: 17594995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.